KOL Seminar Series presents: Application of Structural Biology in Antibody Discovery and Vaccine Development

Dr. Tongqing Zhou is Chief of Structure Bioinformatics Section at Vaccine Research Center, NIAID/NIH and co-head at the Structural Biology Section, Vaccine Research Center, NIAID, NIH. His research is mainly focused on structural basis of broadly neutralizing HIV-1 antibodies, antibody ontogeny that guide the development of broadly neutralizing antibodies, and structure-based design and testing of novel vaccines for HIV. Recently, Dr. Zhou’s research also expanded into other infectious diseases, such as RSV, Influenza, Zika, MERS and HCMV. Dr. Zhou has published more than 70 peer-reviewed research papers in journals including Nature, Science, Cell, Immunity, PNAS. He is a Clarivate Analytics Highly Cited Researcher in Microbiology in 2014, 2015 and 2017. Dr. Zhou received B.S. in Biochemistry from Wuhan University, China, in 1989 and Ph.D. in Cell Biology from the Chinese Academy of Sciences in 1994. Before joining the VRC in September 2001, Dr. Zhou was a postdoctoral research associate at Wayne State University School of Medicine, where he obtained his x-ray crystallography training and M. S. in Electrical and Computer Controlled Systems.
For more information on GenScript KOL seminar series, please contact GenScriptTechsupport@genscript.com.